{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,10]],"date-time":"2026-06-10T12:23:35Z","timestamp":1781094215474,"version":"3.54.1"},"reference-count":37,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2021,2,1]],"date-time":"2021-02-01T00:00:00Z","timestamp":1612137600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,2,1]],"date-time":"2021-02-01T00:00:00Z","timestamp":1612137600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/501100002322","name":"Coordena\u00e7\u00e3o de Aperfei\u00e7oamento de Pessoal de N\u00edvel Superior","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100002322","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Sexual & Reproductive Healthcare"],"published-print":{"date-parts":[[2021,2]]},"DOI":"10.1016\/j.srhc.2020.100587","type":"journal-article","created":{"date-parts":[[2020,12,27]],"date-time":"2020-12-27T17:29:44Z","timestamp":1609090184000},"page":"100587","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":6,"special_numbering":"C","title":["Combined hormonal contraceptives use among women with contraindications according to the WHO criteria: A systematic review"],"prefix":"10.1016","volume":"27","author":[{"given":"Gb\u00e8nankpon Mathias","family":"Houv\u00e8ssou","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Simone","family":"Far\u00edas-Ant\u00fanez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mari\u00e2ngela Freitas","family":"da Silveira","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"1","key":"10.1016\/j.srhc.2020.100587_b0005","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1016\/j.beem.2012.11.004","article-title":"History of oral contraceptive drugs and their use worldwide","volume":"27","author":"Christin-Maitre","year":"2013","journal-title":"Best Pract Res Clin Endocrinol Metab"},{"key":"10.1016\/j.srhc.2020.100587_b0010","unstructured":"Daniels K, Mosher WD, Jones J. Contraceptive methods women have ever used: United States, 1982-2010. National Health Statistics Report; 2013. p. 1\u201315."},{"issue":"Suppl","key":"10.1016\/j.srhc.2020.100587_b0015","doi-asserted-by":"crossref","first-page":"S4","DOI":"10.1016\/j.ajog.2011.06.056","article-title":"The state of hormonal contraception today: established and emerging noncontraceptive health benefits","volume":"205","author":"Maguire","year":"2011","journal-title":"Am J Obstet Gynecol"},{"key":"10.1016\/j.srhc.2020.100587_b0020","series-title":"Contraceptive technology","first-page":"193","author":"Hatcher","year":"2009"},{"key":"10.1016\/j.srhc.2020.100587_b0025","doi-asserted-by":"crossref","first-page":"h2135","DOI":"10.1136\/bmj.h2135","article-title":"Use of combined oral contraceptives and risk of venous thromboembolism: nested case-control studies using the Qresearch and CPRD databases","volume":"350","author":"Vinogradova","year":"2015","journal-title":"BMJ"},{"key":"10.1016\/j.srhc.2020.100587_b0030","doi-asserted-by":"crossref","first-page":"i2002","DOI":"10.1136\/bmj.i2002","article-title":"Low dose oestrogen combined oral contraception and risk of pulmonary embolism, stroke, and myocardial infarction in five million French women: cohort study","volume":"353","author":"Weill","year":"2016","journal-title":"BMJ"},{"key":"10.1016\/j.srhc.2020.100587_b0035","doi-asserted-by":"crossref","first-page":"f5298","DOI":"10.1136\/bmj.f5298","article-title":"Different combined oral contraceptives and the risk of venous thrombosis: systematic review and network meta-analysis","volume":"347","author":"Stegeman","year":"2013","journal-title":"BMJ"},{"issue":"10","key":"10.1016\/j.srhc.2020.100587_b0040","doi-asserted-by":"crossref","first-page":"1353","DOI":"10.1517\/14740338.2014.950654","article-title":"Hormonal contraception, thrombosis and age","volume":"13","author":"Lidegaard","year":"2014","journal-title":"Expert Opin Drug Saf"},{"key":"10.1016\/j.srhc.2020.100587_b0045","unstructured":"Food and drugs Administration office of surveillance and Epidemiology. Combined hormonal contraceptives (CHCs) and the risk of cardiovascular disease endpoints. Silver Spring (MD): Food and Drug Administration; 2011."},{"key":"10.1016\/j.srhc.2020.100587_b0050","series-title":"Medical eligibility criteria for contraceptive use","author":"World Health Organization","year":"2015"},{"key":"10.1016\/j.srhc.2020.100587_b0055","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1590\/s1518-8787.2017051006113","article-title":"Factors associated with the contraindicated use of oral contraceptives in Brazil","volume":"51","author":"Corr\u00eaa","year":"2017","journal-title":"Rev Sa\u00fade P\u00fablica"},{"issue":"254\u2013260","key":"10.1016\/j.srhc.2020.100587_b0060","article-title":"Perceptions of the safety of oral contraceptives among a predominantly Latina population in Texas","volume":"81","author":"Grossman","year":"2010","journal-title":"Contraception"},{"issue":"2","key":"10.1016\/j.srhc.2020.100587_b0065","doi-asserted-by":"crossref","DOI":"10.1016\/j.ajog.2017.10.020","article-title":"Medical contraindications to estrogen and contraceptive use among women veterans","volume":"218","author":"Judge","year":"2018","journal-title":"Am J Obstet Gynecol"},{"issue":"6","key":"10.1016\/j.srhc.2020.100587_b0070","doi-asserted-by":"crossref","first-page":"805","DOI":"10.1097\/EDE.0b013e3181577511","article-title":"Strengthening the Reporting of Observational Studies in Epidemiology (STROBE) explanation and elaboration","volume":"18","author":"Vandenbroucke","year":"2007","journal-title":"Epidemiology"},{"key":"10.1016\/j.srhc.2020.100587_b0075","article-title":"Smokers over age 35 continue to receive oral contraceptives: Survey of patients in a family practice residency practice","volume":"18","author":"Ruger","year":"2000","journal-title":"Scand J Prim Health Care"},{"key":"10.1016\/j.srhc.2020.100587_b0080","first-page":"1","article-title":"Impact of UK Medical Eligibility Criteria implementation on prescribing of combined hormonal contraceptives","volume":"00","author":"Briggs","year":"2013","journal-title":"J Family Plan Reprod Health Care"},{"key":"10.1016\/j.srhc.2020.100587_b0085","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1016\/j.contraception.2006.12.022","article-title":"Contraindications to oral contraceptive use among women in the United States, 1999\u20132001","volume":"75","author":"Shortridge","year":"2007","journal-title":"Contraception"},{"issue":"6","key":"10.1016\/j.srhc.2020.100587_b0090","doi-asserted-by":"crossref","first-page":"380","DOI":"10.1016\/j.whi.2010.06.006","article-title":"Cigarette smoking women of reproductive age who use oral contraceptives: Results from the 2002 and 2004 behavioral risk factor surveillance systems","volume":"20","author":"McClave","year":"2010","journal-title":"Women\u2019s Health Issues"},{"issue":"3","key":"10.1016\/j.srhc.2020.100587_b0095","doi-asserted-by":"crossref","DOI":"10.1016\/j.ajog.2016.03.047","article-title":"Combined hormonal contraception use in reproductive age women with contraindications to estrogen use","volume":"215","author":"Lauring","year":"2016","journal-title":"Am J Obstet Gynecol"},{"issue":"4","key":"10.1016\/j.srhc.2020.100587_b0100","doi-asserted-by":"crossref","first-page":"1511","DOI":"10.1353\/hpu.2013.0172","article-title":"Hypertension among oral contraceptive users in El Paso, Texas","volume":"24","author":"White","year":"2013","journal-title":"J Health Care Poor Underserved"},{"issue":"7","key":"10.1016\/j.srhc.2020.100587_b0105","doi-asserted-by":"crossref","first-page":"595","DOI":"10.1089\/jwh.2012.3955","article-title":"Inappropriate use of combined hormonal contraceptives for birth control among women of reproductive age in the United States","volume":"22","author":"Yu","year":"2013","journal-title":"J Women\u2019s Health"},{"issue":"3","key":"10.1016\/j.srhc.2020.100587_b0110","doi-asserted-by":"crossref","first-page":"558","DOI":"10.1097\/AOG.0b013e31820b0244","article-title":"Contraindications to combined oral contraceptives among over-the-counter compared with prescription users","volume":"117","author":"Grossman","year":"2011","journal-title":"Obstet Gynecol Obstet Gynecol"},{"issue":"3","key":"10.1016\/j.srhc.2020.100587_b0115","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1590\/S0102-311X1996000300007","article-title":"Preval\u00eancia de uso de m\u00e9todos contraceptivos e adequa\u00e7\u00e3o do uso de anticoncepcionais orais na cidade de Pelotas, Rio Grande do Sul","volume":"12","author":"Dias da Costa","year":"1996","journal-title":"Brasil Cad Sa\u00fade P\u00fabl"},{"issue":"1","key":"10.1016\/j.srhc.2020.100587_b0120","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1590\/S0102-311X2002000100010","article-title":"Uso de m\u00e9todos anticoncepcionais e adequa\u00e7\u00e3o de contraceptivos hormonais orais na cidade de Pelotas, Rio Grande do Sul, Brasil: 1992 e 1999","volume":"18","author":"Dias-da-Costa","year":"2002","journal-title":"Cad Sa\u00fade P\u00fablica"},{"issue":"2","key":"10.1016\/j.srhc.2020.100587_b0125","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1590\/S0034-89101991000200003","article-title":"Adequa\u00e7\u00e3o do uso de p\u00edlula anticoncepcional entre mulheres unidas","volume":"25","author":"Hardy","year":"1991","journal-title":"Rev Sa\u00fade P\u00fablica"},{"issue":"1","key":"10.1016\/j.srhc.2020.100587_b0130","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1783\/147118908783332203","article-title":"Feasibility of a self-completed history questionnaire in women requesting repeat combined hormonal contraception","volume":"34","author":"Doshi","year":"2008","journal-title":"J Fam Plann Reprod Health Care"},{"key":"10.1016\/j.srhc.2020.100587_b0135","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1159\/000351106","article-title":"Necessity of education for oral contraceptive use in Korea: Results from the Fourth Korean National Health and Nutrition Examination Survey 2007\u20132009","volume":"76","author":"Lee","year":"2013","journal-title":"Gynecol Obstet Invest"},{"issue":"3","key":"10.1016\/j.srhc.2020.100587_b0140","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1111\/j.1728-4465.2006.00098.x","article-title":"Over-the-counter access, changing WHO guidelines, and contraindicated oral contraceptive use in Mexico","volume":"37","author":"Yeatman","year":"2006","journal-title":"Stud Fam Plann"},{"issue":"6","key":"10.1016\/j.srhc.2020.100587_b0145","doi-asserted-by":"crossref","first-page":"762","DOI":"10.1210\/js.2017-00090","article-title":"Combined hormonal contraceptives and first venous thrombosis in young French women: Impact of thrombotic family history","volume":"1","author":"Hugon-Rodin","year":"2017","journal-title":"J Endocr Soc"},{"key":"10.1016\/j.srhc.2020.100587_b0150","article-title":"Combined oral contraceptive use among women with hypertension: a systematic review","volume":"73","author":"Curtis","year":"2006","journal-title":"Contraception"},{"issue":"5","key":"10.1016\/j.srhc.2020.100587_b0155","doi-asserted-by":"crossref","DOI":"10.1016\/j.ajog.2016.12.019","article-title":"Use of combined hormonal contraceptives among women with migraines and risk of ischemic stroke","volume":"216","author":"Champaloux","year":"2017","journal-title":"Am J Obstet Gynecol"},{"issue":"653\u20138","key":"10.1016\/j.srhc.2020.100587_b0160","article-title":"Progestin only contraceptive pill use among women in the United States","volume":"86","author":"Hall","year":"2012","journal-title":"Contraception"},{"key":"10.1016\/j.srhc.2020.100587_b0165","unstructured":"Faculty of Sexual and Reproductive Healthcare. UK medical eligibility criteria for contraceptive use; 2009. http:\/\/www.fsrh.org\/pdfs\/UKMEC2009.pdf [accessed 26 February 2012]."},{"key":"10.1016\/j.srhc.2020.100587_b0170","unstructured":"Haute Autorit\u00e9 de Sant\u00e9. Contraception chez l\u2019homme et la femme [Internet]; 2013. Available at: http:\/\/www. has-sante.fr\/portail\/upload\/docs\/application\/pdf\/2015-02\/contraception_fiches_memo_rapport_delaboration.Pdf."},{"key":"10.1016\/j.srhc.2020.100587_b0175","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1016\/j.contraception.2006.02.010","article-title":"Disparities in contraceptive knowledge, attitude and use between Hispanic and nonHispanic whites","volume":"74","author":"Sangi-Haghpeykar","year":"2006","journal-title":"Contraception"},{"key":"10.1016\/j.srhc.2020.100587_b0180","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1016\/j.contraception.2004.04.013","article-title":"Concerns about contraceptive side effects among young Latinas: a focus-group approach","volume":"70","author":"Gilliam","year":"2004","journal-title":"Contraception"},{"key":"10.1016\/j.srhc.2020.100587_b0185","doi-asserted-by":"crossref","first-page":"1527","DOI":"10.1097\/01.AOG.0000423818.85283.bd","article-title":"Over-the-counter access to oral contraceptives","volume":"120","author":"Committee Opinion No 544","year":"2012","journal-title":"Obstet Gynecol"}],"container-title":["Sexual & Reproductive Healthcare"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1877575620302275?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1877575620302275?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,30]],"date-time":"2025-10-30T04:59:05Z","timestamp":1761800345000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1877575620302275"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,2]]},"references-count":37,"alternative-id":["S1877575620302275"],"URL":"https:\/\/doi.org\/10.1016\/j.srhc.2020.100587","relation":{},"ISSN":["1877-5756"],"issn-type":[{"value":"1877-5756","type":"print"}],"subject":[],"published":{"date-parts":[[2021,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Combined hormonal contraceptives use among women with contraindications according to the WHO criteria: A systematic review","name":"articletitle","label":"Article Title"},{"value":"Sexual & Reproductive Healthcare","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.srhc.2020.100587","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"100587"}}